Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5731 to 5745 of 8904 results

  1. Incentives aimed at individuals, family members and carers: What is the effectiveness and acceptability of incentives to increase uptake of routine vaccines in the UK?

    Recommendation ID NG218/02 Question Incentives aimed at individuals, family members and carers: What is the effectiveness and acceptability

  2. Ways of providing advocacy services: What is the effectiveness and acceptability of providing advocacy through different approaches?

    Recommendation ID NG227/01 Question Ways of providing advocacy services: What is the effectiveness and acceptability of providing advocacy

  3. Quasi-mandation of vaccinations: What is the effectiveness and acceptability of quasi-mandation to increase vaccine uptake of routine vaccines?

    Recommendation ID NG218/03 Question Quasi-mandation of vaccinations: What is the effectiveness and acceptability of quasi-mandation to

  4. School-based versus GP-based catch-up campaigns: What is the effectiveness and acceptability of school-based catch-up vaccination sessions compared with GP-based catch-up campaigns in the UK?

    Recommendation ID NG218/10 Question School-based versus GP-based catch-up campaigns: What is the effectiveness and acceptability of school-based

  5. Responding to an escalation of need: What is the effectiveness and acceptability of social work interventions to support people with complex needs during an escalation of need?

    Recommendation ID NG216/04 Question Responding to an escalation of need: What is the effectiveness and acceptability of social work interventions

  6. What is the effectiveness and cost effectiveness of a trial of hydrolysed formula in formula-fed infants with frequent regurgitation associated with marked distress?

    Recommendation ID NG1/2 Question What is the effectiveness and cost effectiveness of a trial of hydrolysed formula in formula-fed infants

  7. Biological therapies for peripheral spondyloarthritis:- What is the effectiveness and cost effectiveness of biological DMARDs in people with persistent peripheral spondyloarthritis (excluding psoriatic arthritis) or undifferentiated spondyloarthritis?

    Recommendation ID NG65/5 Question Biological therapies for peripheral spondyloarthritis:- What is the effectiveness and cost effectiveness

  8. Models of care and support at home:- What is the effectiveness and cost effectiveness of care and support models (for example, assistive technology) for people growing older with learning disabilities to enable them to live in the family home?

    Recommendation ID NG96/1 Question Models of care and support at home:- What is the effectiveness and cost effectiveness of care and support

  9. Continuous glucose monitoring in children and young people with type 2 diabetes: What is the effectiveness and cost effectiveness of continuous glucose monitoring devices in children and young people with type 2 diabetes?

    Recommendation ID NG18/01 Question Continuous glucose monitoring in children and young people with type 2 diabetes: What is the effectiveness

  10. What is the comparative effectiveness and cost effectiveness of exercise referral schemes compared with other interventions that aim to help people to become more physically active? Relative effectiveness and cost effectiveness should be compared in controlled trials.

    Recommendation ID PH54/4 Question What is the comparative effectiveness and cost effectiveness of exercise referral schemes compared with

  11. Pharmacological management of peripheral spondyloarthritis:- What is the comparative effectiveness and cost effectiveness of standard DMARDs for managing peripheral spondyloarthritis, and is this effectiveness affected by differences in dose escalation protocols?

    Recommendation ID NG65/4 Question Pharmacological management of peripheral spondyloarthritis:- What is the comparative effectiveness and